Drug intelligence / Profile preview

EBS amino acid formulation

Development stage
Preclinical
Lead developer
Entrinsic Bioscience
Administration
Oral
01

Overview

EBS amino acid formulation refers to a **proprietary amino acid-based formulation platform** developed by Entrinsic Bioscience rather than a single well-defined pharmaceutical active ingredient. Publicly available descriptions indicate that Entrinsic has developed patented, selective amino acid blends intended to improve intestinal barrier function, nutrient absorption, and electrolyte and fluid uptake, including an amino acid-based oral rehydration solution concept described as AA-ORS. Reported proposed effects include enhancement of villus structure, reduction of epithelial anion channel activity, and improved net intestinal absorption without relying on glucose. The program appears to have been explored in gastrointestinal and hydration-related settings such as infectious diarrhea, diarrhea-predominant irritable bowel syndrome, exercise or heat stress associated gut permeability, and oncology supportive care formulations, but the exact ingredient composition and a single standardized product identity for the queried term are not clearly disclosed in the available sources.

Other names
EBS amino acid formulationEntrinsic amino acid formulationAA-ORS

Beyond the preview

Go deeper on EBS amino acid formulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EBS amino acid formulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call